THEMIS MEDICARE LTD.

Themis Medicare Ltd has rescheduled its Board Meeting from November 5, 2026, to November 14, 2026. The meeting will be held on Saturday, November 14, 2026, to approve the standalone and consolidated unaudited financial results for the quarter and half-year ended September 30, 2026. The change is due to unavoidable circumstances. The trading window for designated persons will remain closed until 48 hours after the financial results are made public.

CTL Trusteeship Limited, acting as debenture trustee for OSS Software Solutions Labs Private Limited, has disclosed the creation of an encumbrance on Themis Medicare Limited shares. Vividhmargi Trust, which held 2,83,17,620 shares (30.75%), has pledged an additional 40,00,000 equity shares (4.34%) in favor of the debenture trustee. This increases the total pledged shares to 3,23,17,620, representing 35.09% of the total diluted share capital.

Vividhmargi Investments Pvt Ltd, a promoter of Themis Medicare Limited, has disclosed the pledge of 25,00,000 equity shares (representing 4.05% of promoter holding and 2.71% of total share capital) on October 27, 2026. This pledge is in favor of CTL Trusteeship Limited, acting as Debenture Trustee, in relation to Unrated, Unlisted, Secured, Redeemable Non-Convertible Debentures issued by OSS Software Solutions Labs Private Limited. The total amount involved against which shares have been encumbered is ₹135 Crore, with the value of shares on the date of the event being ₹23.80 Crore. The end use of the borrowed funds is for personal use by promoters and PACs.

Vividhmargi Investments Private Limited, a promoter of Themis Medicare Limited, has disclosed the encumbrance of 25,00,000 equity shares (4.05% of promoter holding) through a pledge. This pledge was created on October 27, 2026, in favor of CTL Trusteeship Limited, acting as Debenture Trustee for NCDs issued by OSS Software Solutions Labs Private Limited. The value of the encumbered shares at the time of the event was approximately ₹23.80 Crore, against an amount involved of ₹135 Crore. The end use of the borrowed funds is stated as personal use by promoters and PACs.

Themis Medicare Limited has announced that its Board of Directors will convene on November 5, 2026. The primary agenda for this meeting is to consider and approve the un-audited standalone and consolidated financial results for the quarter and half-year ended September 30, 2026. The meeting will also review the Limited Review Reports from the Statutory Auditors. Concurrently, the company has informed its 'Designated Persons' about the closure of the Trading Window from October 1, 2026, until 48 hours after the financial results are published, in compliance with SEBI's Insider Trading Regulations.

Vividhmargi Investments Private Limited, a promoter of Themis Medicare Limited, has disclosed the encumbrance of 15,00,000 equity shares, representing 1.63% of the total share capital. This pledge was created on October 22, 2026, against borrowings in favor of CTL Trusteeship Limited, acting as Trustee for Kotak Credit Opportunities Fund. The promoter's total holding is 2,44,29,460 shares (26.52%), with 30,00,000 shares (3.26%) previously encumbered. This disclosure is made in compliance with SEBI (SAST) Regulations, 2011.

Vividhmargi Investments Private Limited, a promoter of Themis Medicare Limited, has disclosed the pledge of 15,00,000 equity shares, representing 1.63% of the total share capital. This pledge was created on October 22, 2026, against borrowings in favor of CTL Trusteeship Limited, acting as trustee for Kotak Credit Opportunities Fund. The disclosure was made on October 23, 2026, in compliance with SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011. Vividhmargi Investments currently holds 26.52% of Themis Medicare's total promoter shareholding.

Themis Medicare Ltd has initiated the process for the re-appointment of Mr. Bhaskar Vemban Iyer as an Independent Director. His current term concludes on November 11, 2026. The Board of Directors, based on the Nomination and Remuneration Committee's recommendation and a positive performance evaluation, proposes a second consecutive five-year term for Mr. Iyer, commencing November 12, 2026. A Postal Ballot Notice seeking shareholder approval for this re-appointment has been dispatched to all members on October 23, 2026, and is also available on the company's website.

Themis Medicare Ltd announced that its members have approved a dividend of Re. 0.50 per equity share, amounting to a total of ₹4,60,50,060 for the Financial Year ended March 31, 2026. Additionally, the company's Articles of Association (AOA) have been amended. Specifically, Article 13(1) Clause (c) was modified by deleting a condition related to valuation reports for share price determination. The amended clause now allows for share transactions for cash or other consideration without the previous valuation requirement.

Themis Medicare Limited held its 56th Annual General Meeting (AGM) on September 30, 2026. The meeting, which commenced at 11:00 a.m. and concluded at 11:35 a.m. at the company's registered office in Vapi, Gujarat, deliberated on several key business items. These included the adoption of audited standalone and consolidated financial statements for the fiscal year ended March 31, 2026, the re-appointment of a director retiring by rotation, and the declaration of dividends on equity shares. Additionally, special businesses such as the ratification of the Cost Auditor's remuneration for FY 2026-27 and amendments to the Articles of Association were presented for shareholder approval. The company provided remote e-voting facilities and ballot paper voting at the meeting. Results of the voting will be disseminated within two working days.